Ophthalmic Apparatus with Integrated Synergistic Technologies

Publication ID: 24-11857255_0008_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Ophthalmic Apparatus with Integrated Synergistic Technologies,” Published Technical Disclosure No. 24-11857255_0008_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857255_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,255.

Summary of the Inventive Concept

An advanced ophthalmic apparatus combining the original patented concept with cutting-edge technologies like AI, IoT, blockchain, and nanomaterials to enhance diagnostic accuracy, patient data security, and remote monitoring capabilities.

Background and Problem Solved

The original ophthalmic apparatus patent addressed the need for accurate measurement of specific eye parts. However, it lacked the integration of emerging technologies to provide a more comprehensive and secure diagnostic experience. The new inventive concept bridges this gap by incorporating AI-driven analysis, IoT-enabled real-time monitoring, blockchain-secured data storage, and nanomaterial-based biomarker detection.

Detailed Description of the Inventive Concept

The ophthalmic apparatus integrates an artificial intelligence module to analyze images of the target part and provide a diagnosis of an eye condition. It also incorporates a blockchain-based secure data storage system to store and verify images and diagnosis results. Additionally, the apparatus is integrated with an IoT device, enabling real-time monitoring and remote control. Furthermore, a nanomaterial-based sensor detects biomarkers in the eye, providing an early warning of an eye condition. The system can also utilize machine learning algorithms to predict eye condition progression.

Novelty and Inventive Step

The new claims introduce novel synergies between the original ophthalmic apparatus and distinct technologies, creating a more powerful and secure system. The inventive step lies in the integration of these technologies to provide a comprehensive diagnostic experience, enhancing accuracy, security, and patient care.

Alternative Embodiments and Variations

Alternative embodiments may include integrating the ophthalmic apparatus with other emerging technologies, such as augmented reality or 5G connectivity. Variations may also include adapting the system for use in different medical specialties or developing portable, handheld devices.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare industry, particularly in ophthalmology and optometry. It can be marketed as a premium diagnostic solution, offering enhanced accuracy, security, and patient convenience. Target industries include hospitals, clinics, and private medical practices.

CPC Classifications

SectionClassGroup
A A61 A61B3/0025
A A61 A61B3/0041
A A61 A61B3/102

Original Patent Information

Patent NumberUS 11,857,255
TitleOphthalmic apparatus
Assignee(s)Tomey Corporation